Schizophrenia Awareness and New Long-Acting Treatment
Christoph Correll, Professor of Psychiatry at the Zucker School of Medicine discusses common misconceptions about schizophrenia and the challenges that ...
5345 articles
Christoph Correll, Professor of Psychiatry at the Zucker School of Medicine discusses common misconceptions about schizophrenia and the challenges that ...
Michael Racke, a board-certified neurologist and medical director of neurology at Quest Diagnostics, discusses the advances in blood and other tests for...
Shubh Goel, VP, Head of Immuno-Oncology and GI Tumors Franchise at AstraZeneca discusses data presented at the European Society for Medical Oncology (ES...
Juan Vera, CEO of Marker Therapeutics, a clinical-stage immuno-oncology company focused on developing next-generation T cell-based immunotherapies for t...
Andrew Cutler, Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University and CEO of Florida Clinical Research Center, LLC discusses ...
David Longo, Co-Founder and CEO of Ordaōs, an AI-driven drug design company, discusses generative AI and how Ordaos is using AI to design novel and cus...
Aetion Chief Science Officer, Nicolle Gatto, Ph.D., M.P.H., shares how the organization leverages real-world evidence (RWE) to support research and deve...
Introduction You, as an amazing team leader, care about your employees. Learn more on Health Professional Radio.
David Rosmarin, Ph.D, is the Director of the Spirituality and Mental Health Program at McLean Hospital, associate professor of psychology in the Departm...
Jaideep Singh, Co-Founder and CEO of Ambee talks about his passion for the environment, helping people improve their lives, and the groundbreaking envir...